Thomas Matthew Habermann, MD

  • 19802 Citations
  • 72 Scopus h-Index
1978 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Thomas Matthew Habermann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1978 2017

Lymphoma Specialized Program of Research Excellence

Macon, W. R., Dogan, A. M., Ansell, S. M., Gupta, M. D., Witzig, T. E., Cerhan, J. R., Habermann, T. M., Ratliff, T. L., Link, B. K., Ratliff, T. L., Juweid, M., Ballas, Z., Link, B. K., Ratliff, T., Geyer, S. M., Weiner, G., Lentz, S., Hohl, R., Smith, B. J., Kaufmann, S. H., Feldman, A. L. & Witzig, T. E.

National Institutes of Health

9/11/026/30/17

Project: Research project

Lymphoma
Non-Hodgkin's Lymphoma
Molecular Epidemiology
B-Lymphocytes
B-Cell Lymphoma

EASTERN COOPERATIVE ONCOLOGY GROUP

Habermann, T. M., Hahn, R. & Edmonson, J.

National Institutes of Health

6/1/784/30/16

Project: Research project

Antineoplastic Protocols
Organized Financing
Neoplasms
Research
Clinical Protocols

Research Output 1983 2019

4 Citations (Scopus)

Cause of death in follicular lymphoma in the first decade of the rituximab era: A pooled analysis of French and US cohorts

Sarkozy, C., Maurer, M. J., Link, B. K., Ghesquieres, H., Nicolas, E., Thompson, C. A., Traverse-Glehen, A., Feldman, A. L., Allmer, C., Slager, S. L., Ansell, S. M., Habermann, T. M., Bachy, E., Cerhan, J. R. & Salles, G., Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 144-152 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Cause of Death
Lymphoma
Disease-Free Survival
Rituximab
Follicular Lymphoma
Spleen
Bone and Bones
Survival
Disease-Free Survival

Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study

Wang, Y., Habermann, T. M., Wang, S. S., Maurer, M. J., Sarangi, V., Link, B. K., Feldman, A. L., Inwards, D. J., Witzig, T. E., Cozen, W., Rothman, N., Asmann, Y., Slager, S. L. & Cerhan, J. R., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalLetter

Open Access
Mantle-Cell Lymphoma
Tumor Necrosis Factor-alpha

Impact of early rasburicase on incidence of clinical tumor lysis syndrome in lymphoma

Personett, H. A., Barreto, E. F., McCullough, K. B., Dierkhising, R., Leung, N. & Habermann, T. M., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Tumor Lysis Syndrome
Acute Kidney Injury
Lymphoma
Incidence
Uric Acid

Impact of lymphoma survivorship clinic visit on patient-centered outcomes

Viscuse, P., Yost, K. J., Jenkins, S., Lackore, K., Habermann, T. M., Thanarajasingam, G. & Thompson, C. A., Jan 1 2019, In : Journal of Cancer Survivorship.

Research output: Contribution to journalArticle

Ambulatory Care
Lymphoma
Survival Rate
Survivors
Neoplasms